LLY
Eli Lilly and Company
LLY has the edge over SNDL overall, supported by stronger fundamentals and stronger modeled upside.
SNDL
SNDL Inc.
SNDL trails on the overall score without a compensating advantage in the available component scores.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
SNDL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
SNDL's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
SNDL PE Valuation
SNDL has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LLY has the edge over SNDL on the outlook, with more favorable revenue and profitability expectations.
SNDL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Stable | |
| Limited | |
| High |
Analysts expect SNDL's losses to shrink, with revenue declining.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over SNDL on earnings quality, reporting a profit while its opponent remains loss making.
SNDL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.18 | +$0.07 |
| Q2 2026 | -$0.07 | +$0.20 |
| Q1 2026 | -$0.04 | +$0.25 |
| Q4 2025 | -$0.05 | +$0.21 |
| Q3 2025 | -$0.25 | +$0.04 |
| Q2 2025 | -$0.27 | +$0.03 |
| Q1 2025 | -$0.29 | +$0.08 |
| Q4 2024 | -$0.26 | +$0.20 |
SNDL is still losing money, but far less than before: $0.18 per share over the past year, against $23.08 at its worst in mid-2020.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over SNDL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over SNDL on profitability, with a higher operating margin.
SNDL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $165.7M | -3.5% |
| Q2 2026 | $165.8M | -3.7% |
| Q1 2026 | $137.7M | -4.4% |
| Q4 2025 | $177.5M | -2% |
| Q3 2025 | $171.7M | +3.1% |
| Q2 2025 | $172.1M | +7.3% |
| Q1 2025 | $144.1M | +3.6% |
| Q4 2024 | $181.2M | +3.7% |
SNDL's revenue grew through 2023 and has held roughly level since: $166M last quarter, down 3.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.4% | +2.5 points |
| Q2 2026 | -2.3% | -3.5 points |
| Q1 2026 | -5.7% | -1.7 points |
| Q4 2025 | 4.1% | +34 points |
| Q3 2025 | -3.8% | +4 points |
| Q2 2025 | 1.2% | +3.3 points |
| Q1 2025 | -4% | -1.8 points |
| Q4 2024 | -30% | +4.7 points |
SNDL's operating margin was −1.4% last quarter, up 2.5 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over SNDL on cash flow, with more consistent year-over-year improvement.
SNDL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $12.1M | -35% |
| Q2 2026 | $1.3M | -53% |
| Q1 2026 | $592.7K | -86% |
| Q4 2025 | $15M | +2.5% |
| Q3 2025 | $18.6M | +42% |
| Q2 2025 | $2.8M | +15% |
| Q1 2025 | $4.4M | +648% |
| Q4 2024 | $14.6M | +84% |
SNDL generated $29M in free cash flow over the past year, down 28% from the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has 893M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
SNDL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.8% | -9.7M shares |
| 1 year | -4% | -10.4M shares |
| 3 years | -5.2% | -13.5M shares |
| 5 years | +20% | +41.3M shares |
| Available history | +2217% | +236M shares |
SNDL has the edge over LLY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6.7M |
| Q2 2026 | $16.5M |
| Q1 2026 | $6.7M |
| Q4 2025 | $220,754 |
| Q3 2025 | $2,109 |
| Q2 2025 | — |
| Q1 2025 | $10.6M |
| Q4 2024 | $9.3M |
SNDL spent $30M buying back its own shares over the past year, up 52% from the year before.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
SNDL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -2.1x | Net Cash |
SNDL has the edge over LLY on leverage, with a lower net debt burden relative to earnings.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
SNDL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.8 | Neutral |
| Stochastic | 66.2 | Neutral |
SNDL's weekly RSI is 52 (neutral) and its Stochastic is 66 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
SNDL PE vs Healthcare Sector
SNDL has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over SNDL on trend strength, trading above more of its moving averages.
SNDL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.31 | 6.1% above |
| 20 week MA | $1.31 | 6.1% above |
| 50 week MA | $1.45 | 4.1% below |
| 100 week MA | $1.60 | 13% below |
| 200 week MA | $1.69 | 18% below |
SNDL has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 18% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over SNDL on returns for 2026, with the stronger performance.
SNDL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.7 | $4.73 | -79% |
| 2021 | $4.73 | $6.70 | +42% |
| 2022 | $6.70 | $2.08 | -69% |
| 2023 | $2.08 | $1.64 | -21% |
| 2024 | $1.64 | $1.79 | +9.1% |
| 2025 | $1.79 | $1.73 | -3.4% |
| 2026 YTD | $1.73 | $1.39 | -20% |
SNDL has finished lower in four of the last six years. It's down 20% so far in 2026.